http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-60304484-T2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-056
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H13-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-056
filingDate 2003-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2006-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3160dfb496581b7659023fac79f22c69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61aa601c0471de8ab31e6777a5c9d323
publicationDate 2006-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-60304484-T2
titleOfInvention METHOD FOR THE PRODUCTION OF A RIBOFURANOSE
abstract A method of converting pure alpha-anomer or beta/alpha-anomer mixtures of 1,2,3,5-tetra-O-acetyl-L-ribofuranose to methyl-1-(2,3,5-tri-O-acetyl-beta-L-ribofuranosyl)-1,2,4-triazole-3-carboxylate an intermediate for levovirin, as well as, the novel pure alpha-anomer, alpha 1,2,3,5-tetra-O-acetyl-L-ribofuiranose, are useful in manufacturing levovirin.
priorityDate 2002-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467471165

Total number of triples: 15.